PR

MEZOO, connecting health through technology
Sharing MEZOO’s technology and vision.
External
2025.09.17
[KHF 2025] Dong-A ST Accelerates Digital Healthcare Expansion with “HiCardi”… “Targeting KRW 100 Billion in Revenue by 2030”

 

Dong-A ST is accelerating the expansion of its digital healthcare business by prominently showcasing the remote patient monitoring device “HiCardi” at Korea’s largest digital healthcare exhibition, KHF 2025.

 

HiCardi is a Remote Patient Monitoring (RPM) platform developed by digital healthcare company Mezoo. In July 2022, Dong-A ST secured exclusive domestic distribution rights for the platform. The company is currently conducting active marketing efforts targeting a wide range of medical institutions, including tertiary hospitals, general hospitals, specialty hospitals, and clinics.

 

Hee-bong Park, Head of the Digital Healthcare Business Division at Dong-A ST, stated that the most important task at present is to effectively raise awareness of the new remote monitoring solution among medical institutions. He noted that the primary short-term goal is to successfully establish ongoing projects being introduced at tertiary hospitals. He further emphasized that Dong-A ST will concentrate its capabilities to ensure that digital healthcare becomes a core pillar as the company evolves into a total healthcare enterprise.


http://www.paxetv.com

 

적용 법률 및 규정
의료기기

하이카디® 시스템은 인허가에 따라 신생아, 소아, 청소년, 18세 이상 환자의 ECG 데이터를 측정하여 부정맥을 진단하는 의료기기로서 의료전문가가 사용하도록 설계되었습니다. 한국 KFDA로부터 의료기기 2등급 인증을 받았습니다. 유럽의료기기 지침(2007/47/EC에 따라 개정된 MDD 93/42/EEC)에 따라 준수된 Class IIb (CE2265). 의료기기 제품으로 CE 승인되었습니다. 미국 FDA는 Class II 510K로 승인 완료 예정입니다.

경고

본 자료는 의료 전문가에게만 배포되며 관련 사진과 함께 제공되는 자료와 관련하여 그 어떤 법적인 책임을 갖지 않습니다. 사용 전 사용 지침서를 주의 깊게 읽으십시오.